These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29109896)

  • 1. Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema.
    Akıncıoğlu D; Küçükevcilioğlu M; Durukan AH; Aykaş S; Ayyıldız Ö; Erdurman FC
    Turk J Ophthalmol; 2017 Oct; 47(5):274-278. PubMed ID: 29109896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series.
    Rishi P; Rishi E; Kuniyal L; Mathur G
    Oman J Ophthalmol; 2012 May; 5(2):79-82. PubMed ID: 22993460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.
    Elhamid AHA
    Open Ophthalmol J; 2017; 11():164-172. PubMed ID: 28839510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
    Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
    Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
    Kaldırım H; Savur F; Kırgız A; Atalay K
    Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
    Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
    Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Ozurdex implant in recalcitrant diabetic macular edema--a single-center experience.
    Bansal P; Gupta V; Gupta A; Dogra MR; Ram J
    Int Ophthalmol; 2016 Apr; 36(2):207-16. PubMed ID: 26233578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema.
    Rishi P; Rishi E; Attiku Y; Dhami A; Iyer V
    GMS Ophthalmol Cases; 2020; 10():Doc21. PubMed ID: 32676266
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
    Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y
    Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
    Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
    BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
    Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
    Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes.
    Neves P; Ornelas M; Matias I; Rodrigues J; Santos M; Dutra-Medeiros M; Martins D
    Int J Ophthalmol; 2021; 14(10):1571-1580. PubMed ID: 34667735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
    Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
    Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
    Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
    Mishra SK; Sinha S; Chauhan R; Kumar A
    Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.